TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Dr. Reddy’s Laboratories Ltd. ( (IN:DRREDDY) ).
Dr. Reddy’s Laboratories Ltd. has submitted a confirmation certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ending September 30, 2025. This submission ensures that securities received for dematerialization have been processed and listed appropriately, reflecting the company’s adherence to regulatory compliance and its ongoing commitment to maintaining transparency and trust with its stakeholders.
More about Dr. Reddy’s Laboratories Ltd.
Dr. Reddy’s Laboratories Ltd. operates in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of a wide range of generic medicines. The company is known for its commitment to providing affordable and innovative healthcare solutions.
Average Trading Volume: 81,003
Technical Sentiment Signal: Buy
Current Market Cap: 1030.4B INR
See more data about DRREDDY stock on TipRanks’ Stock Analysis page.